Zhuhai Port Completes the Acquisition of 11.96% Interest in Tian Lun Gas, Officially Becomes the Second Largest Shareholder
Enters into Strategic Cooperation Agreement with Zhuhai Port to Explore In-depth Cooperation in the Field…
5 years ago
GetSwift Announces Heads of Agreement for Proposed Settlement of Australian Class Action
NEW YORK--(BUSINESS WIRE)--GetSwift Technologies Limited (NEO: GSW) (“GetSwift” or the “Company”), a leading provider of…
5 years ago
CANbridge Pharmaceuticals CAN106 Investigational New Drug Application Approved in China for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company…
5 years ago
Phi Finney McDonald Announces Settlement Reached in GetSwift Class Action
SYDNEY--(BUSINESS WIRE)--A conditional settlement agreement has been reached in the class action against GetSwift Limited…
5 years ago
Renesas Launches High-Reliability Radiation-Hardened Plastic Portfolio for Satellites in Medium and Geosynchronous Earth Orbits
New Lineup Provides High Reliability and Reduced SWaP; Co-Packaged Solution for Space Delivers World-Class GaN…
5 years ago
Behavox Deepens Commitment to Japan in New Partnership With Nomura Research Institute
Partnership broadens Behavox’s reach in delivering data insights solutions that protect the country’s -- and…
5 years ago
Australia Buy Now Pay Later (BNPL) Markets and Investment Opportunities Report 2021-2028 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Australia Buy Now Pay Later Business and Investment Opportunities (2019-2028) Databook - 75+…
5 years ago
Japan Buy Now Pay Later Markets and Investment Opportunities Report 2021: Payments is Expected to Grow by 137.5% – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Japan Buy Now Pay Later Business and Investment Opportunities (2019-2028) Databook - 75+…
5 years ago
Bio-Thera Solutions Announces the First Patient Dosed in Phase III Clinical Trial for BAT2206, a Proposed Biosimilar of Stelara® (Ustekinumab)
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage pharmaceutical company, today announced that the first…
5 years ago
Wicked Kitchen™ Announces $14 Million Series A Funding to Supercharge the Plant-Based Food Movement in the U.S.
MINNEAPOLIS--(BUSINESS WIRE)--Wicked Kitchen, the renowned plant-based food brand and U.K. market leader in plant-based meals,…
5 years ago